Glucosphingolipids as sites of action in the chemotherapy of cancer
- 1 August 1988
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (15) , 2879-2886
- https://doi.org/10.1016/0006-2952(88)90271-7
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Detection of Malignant TumorsNew England Journal of Medicine, 1986
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progressionFEBS Letters, 1986
- Gangliosides and neutral glycosphingolipids of normal tissue and oat cell carcinoma of human lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Somatic events unmask recessive cancer genes to initiate malignancyJournal of Cellular Biochemistry, 1986
- Ganglioside composition of human neuroblastomas correlation with prognosis A pediatric oncology group studyCancer, 1985
- Inhibition of Sphingolipid Synthesis by Cycloserine In Vitro and In VivoJournal of Neurochemistry, 1984
- Cyclic AMP as a mitotic signal for epidermal keratinocytes, but not for dermal fibroblasts.Cell Structure and Function, 1982
- Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumorsBiochemical and Biophysical Research Communications, 1978
- Tumor‐Associated Glycolipid Antigens and Modified Blood Group AntigensScandinavian Journal of Immunology, 1978
- Gangliosides in leukemic and non-leukemic human leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972